These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8774129)
21. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948 [TBL] [Abstract][Full Text] [Related]
22. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
23. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas. Franchi A; Massi D; Santucci M Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884 [TBL] [Abstract][Full Text] [Related]
24. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660 [TBL] [Abstract][Full Text] [Related]
25. Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. Jin Y; Shima Y; Furu M; Aoyama T; Nakamata T; Nakayama T; Nakamura T; Toguchida J Anticancer Res; 2010 Jan; 30(1):245-51. PubMed ID: 20150643 [TBL] [Abstract][Full Text] [Related]
26. Identification of mutations in the Ki-ras gene in human retinoblastoma. Bautista D; Emanuel JR; Granville C; Howard R; Costa J Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2313-7. PubMed ID: 8843915 [TBL] [Abstract][Full Text] [Related]
28. [Malignant fibrous histiocytoma of soft tissue: description of 10 cases]. Povar J; Franco JM; Muñoz JR; Horndler C; Arazo P; Portoles A; Velilla J; Gutiérrez A Med Clin (Barc); 1991 Jan; 96(1):6-10. PubMed ID: 1850813 [TBL] [Abstract][Full Text] [Related]
29. K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients. Cuatrecasas M; Erill N; Musulen E; Costa I; Matias-Guiu X; Prat J Cancer; 1998 Mar; 82(6):1088-95. PubMed ID: 9506354 [TBL] [Abstract][Full Text] [Related]
30. Fibronectin in relation to growth patterns of fibrohistiocytic tumours--an immunohistochemical study of benign and malignant fibrous histiocytomas. Stiller D; Bahn H Acta Histochem; 1987; 82(1):95-108. PubMed ID: 2827424 [TBL] [Abstract][Full Text] [Related]
31. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique. Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419 [TBL] [Abstract][Full Text] [Related]
32. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277 [TBL] [Abstract][Full Text] [Related]
33. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique. Wattanasirichaigoon S; Tasanakhajorn U; Jesadapatarakul S J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030 [TBL] [Abstract][Full Text] [Related]
34. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473 [TBL] [Abstract][Full Text] [Related]
35. Characterization of tumour cells in malignant fibrous histiocytomas and other soft tissue tumours in comparison with malignant histiocytes. I. Immunohistochemical study on paraffin sections. Roholl PJ; Kleyne J; Elbers H; Van der Vegt MC; Albus-Lutter C; Van Unnik JA J Pathol; 1985 Oct; 147(2):87-95. PubMed ID: 2999365 [TBL] [Abstract][Full Text] [Related]
36. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Kumar R; Angelini S; Hemminki K Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681 [TBL] [Abstract][Full Text] [Related]
37. P-53 positivity and high proliferative index: factors of bad prognosis in malignant fibrous histiocytomas. Brinck U; Stachura J; Rudzki Z; Kellner S; Hoefer K; Schauer A In Vivo; 1995; 9(5):475-8. PubMed ID: 8900926 [TBL] [Abstract][Full Text] [Related]
38. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
39. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors. Dobashi Y; Suzuki S; Sugawara H; Ooi A Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509 [TBL] [Abstract][Full Text] [Related]
40. Characterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections. Roholl PJ; Kleyne J; Van Unnik JA Am J Pathol; 1985 Nov; 121(2):269-74. PubMed ID: 2414996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]